These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30793480)

  • 1. Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1.
    Wu J; Liang W; Tian Y; Ma F; Huang W; Jia Y; Jiang Z; Wu H
    J Cell Mol Med; 2019 May; 23(5):3538-3548. PubMed ID: 30793480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1.
    Li Q; Kim YR; Vikram A; Kumar S; Kassan M; Gabani M; Lee SK; Jacobs JS; Irani K
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2394-2403. PubMed ID: 27789474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRT2104 attenuates diabetes-induced aortic endothelial dysfunction via inhibition of P53.
    Wu H; Wu J; Zhou S; Huang W; Li Y; Zhang H; Wang J; Jia Y
    J Endocrinol; 2018 Apr; 237(1):1-14. PubMed ID: 29371235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
    Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
    Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death.
    Jiao D; Zhang H; Jiang Z; Huang W; Liu Z; Wang Z; Wang Y; Wu H
    J Mol Med (Berl); 2018 Sep; 96(9):939-949. PubMed ID: 30030567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
    Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
    Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.
    Guo Y; Li P; Gao L; Zhang J; Yang Z; Bledsoe G; Chang E; Chao L; Chao J
    Aging Cell; 2017 Aug; 16(4):837-846. PubMed ID: 28544111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of SIRT1 promotes high glucose-attenuated corneal epithelial wound healing via p53 regulation of the IGFBP3/IGF-1R/AKT pathway.
    Wang Y; Zhao X; Shi D; Chen P; Yu Y; Yang L; Xie L
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3806-14. PubMed ID: 23661372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-34a aggravates coxsackievirus B3-induced apoptosis of cardiomyocytes through the SIRT1-p53 pathway.
    Jiang D; Li M; Yu Y; Shi H; Chen R
    J Med Virol; 2019 Sep; 91(9):1643-1651. PubMed ID: 30968966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence.
    Chen H; Wan Y; Zhou S; Lu Y; Zhang Z; Zhang R; Chen F; Hao D; Zhao X; Guo Z; Liu D; Liang C
    Sci China Life Sci; 2012 Jun; 55(6):467-73. PubMed ID: 22744176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
    Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
    J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
    Do MT; Kim HG; Choi JH; Jeong HG
    Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway.
    Guo Y; Chao L; Chao J
    J Cell Mol Med; 2018 Sep; 22(9):4387-4398. PubMed ID: 29992759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
    Herbert KJ; Cook AL; Snow ET
    Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
    Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
    Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a Promotes Endothelial Dysfunction and Mitochondrial-mediated Apoptosis in Murine Models of Acute Lung Injury.
    Shah D; Das P; Alam MA; Mahajan N; Romero F; Shahid M; Singh H; Bhandari V
    Am J Respir Cell Mol Biol; 2019 Apr; 60(4):465-477. PubMed ID: 30512967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-34a contributes to diabetes-related cochlear hair cell apoptosis via SIRT1/HIF-1α signaling.
    Lin Y; Shen J; Li D; Ming J; Liu X; Zhang N; Lai J; Shi M; Ji Q; Xing Y
    Gen Comp Endocrinol; 2017 May; 246():63-70. PubMed ID: 28263817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
    Tabuchi T; Satoh M; Itoh T; Nakamura M
    Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
    Sun H; Wang C; Zhou Y; Cheng X
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
    Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
    J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.